Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk Cohorts

被引:14
作者
Aggarwal, Reenika [1 ,2 ]
Lam, Andrew C. L. [1 ,3 ]
McGregor, Maureen [1 ]
Menezes, Ravi [4 ]
Hueniken, Katrina [1 ]
Tateishi, Hannah [1 ,3 ]
O'Kane, Grainne M. [1 ]
Tsao, Ming Sound [5 ,6 ]
Shepherd, Frances A. [1 ]
Xu, Wei [2 ,7 ,8 ]
McInnis, Micheal [9 ]
Schmidt, Heidi [9 ]
Liu, Geoffrey [1 ,2 ,3 ,6 ]
Kavanagh, John [9 ]
机构
[1] Princess Margaret Canc Ctr, Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Epidemiol, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Univ Toronto, Toronto Joint Dept Med Imaging Res, Toronto, ON, Canada
[5] Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[7] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Hlth Network, Biostat, Toronto, ON, Canada
[9] Univ Toronto, Toronto Joint Dept Med Imaging, Dept Cardiothorac Imaging, Toronto, ON, Canada
关键词
Lung cancer; Cancer screening; Low-dose computed tomography; Long-term follow-up; SELECTION CRITERIA; SCREENING TRIAL; PARTICIPANTS; MORTALITY; POPULATION; PROJECT; IMPACT;
D O I
10.1016/j.jtho.2019.01.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: We hypothesize that the incidence of screen-detected lung cancer (LC), in participants with previously negative scans, will be highest in the cohort with the highest baseline risk score. Methods: Individuals with negative baseline screening results from the Princess Margaret International Early Lung Cancer Action Program before 2009 underwent low-dose computed tomography rescreening from 2015 to 2018. Individuals were contacted in order of descending risk, as determined by the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial's PLCOM2012 6-year LC riskprediction model, and then categorized into three risk cohorts according to their baseline risks. The incidence of LC in each risk cohort was determined and compared. Chisquare testing was used for categorical variables and oneway analysis of variance on ranks was used for continuous variables. Results: Of the 1261 participants we attempted to recontact, 359 participants returned for a rescreening scan (mean of 7.6 years between scans). Participants were divided into low (< 2%), moderate (>= 2% to < 3.5%), and high baseline risk (>= 3.5%) cohorts. On average, those in the high-risk cohort compared to the moderate-and low-risk cohorts were older (66 years versus 62 and 59 years) and had a greater smoking history (54 pack-years versus 47 and 29 pack-years). The incidence of cancer in the high-risk cohort was significantly higher than in the moderate-risk cohort (11% versus 1.7%, p = 0.002). Conclusions: There was a significantly higher incidence of LC in the high-risk cohort than in the moderate-risk cohort. The cut-point between the high-and moderate-risk was determined to be greater than or equal to 3.5% of the 6-year baseline risk. (C) 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1003 / 1011
页数:9
相关论文
共 25 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Clapp, Jonathan D.
    Clingan, Kathy L.
    Gareen, Ilana F.
    Lynch, David A.
    Marcus, Pamela M.
    Pinsky, Paul F.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (23): : 1771 - 1779
  • [3] [Anonymous], CMAJ
  • [4] Benefits and Harms of CT Screening for Lung Cancer A Systematic Review
    Bach, Peter B.
    Mirkin, Joshua N.
    Oliver, Thomas K.
    Azzoli, Christopher G.
    Berry, Donald A.
    Brawley, Otis W.
    Byers, Tim
    Colditz, Graham A.
    Gould, Michael K.
    Jett, James R.
    Sabichi, Anita L.
    Smith-Bindman, Rebecca
    Wood, Douglas E.
    Qaseem, Amir
    Detterbeck, Frank C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22): : 2418 - 2429
  • [5] Results of the National Lung Cancer Screening Trial: Where Are We Now?
    Chudgar, Neel P.
    Bucciarelli, Peter R.
    Jeffries, Elizabeth M.
    Rizk, Nabil P.
    Park, Bernard J.
    Adusumilli, Prasad S.
    Jones, David R.
    [J]. THORACIC SURGERY CLINICS, 2015, 25 (02) : 145 - +
  • [6] Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial
    De Koning, H.
    Van der Aalst, C.
    Ten Haaf, K.
    Oudkerk, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S185 - S185
  • [7] Lung Cancer: Epidemiology, Etiology, and Prevention
    Dela Cruz, Charles S.
    Tanoue, Lynn T.
    Matthay, Richard A.
    [J]. CLINICS IN CHEST MEDICINE, 2011, 32 (04) : 605 - +
  • [8] Screen-detected Lung Cancer: A Retrospective Analysis of CT Appearance
    Dhopeshwarkar, Monika R.
    Roberts, Heidi C.
    Paul, Narinder S.
    Dong, Zhi
    Tsao, Ming
    Menezes, Ravi J.
    [J]. ACADEMIC RADIOLOGY, 2011, 18 (10) : 1270 - 1276
  • [9] The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
    Goldstraw, Peter
    Chansky, Kari
    Crowley, John
    Rami-Porta, Ramon
    Asamura, Hisao
    Eberhardt, Wilfried E. E.
    Nicholson, Andrew G.
    Groome, Patti
    Mitchell, Alan
    Bolejack, Vanessa
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) : 39 - 51
  • [10] The impact of overdiagnosis on the selection of efficient lung cancer screening strategies
    Han, Summer S.
    ten Haaf, Kevin
    Hazelton, William D.
    Munshi, Vidit N.
    Jeon, Jihyoun
    Erdogan, Saadet A.
    Johanson, Colden
    McMahon, Pamela M.
    Meza, Rafael
    Kong, Chung Yin
    Feuer, Eric J.
    de Koning, Harry J.
    Plevritis, Sylvia K.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) : 2436 - 2443